Mast Cell Tryptase Promotes Inflammatory Bowel Disease-Induced Intestinal Fibrosis.

Abstract

BACKGROUND:

Intestinal fibrosis is the final pathological outcome of chronic intestinal inflammation without specific therapeutic drugs, which leads to ileus and surgical intervention. Intestinal fibrosis is characterized by excessive deposition of extracellular matrix (ECM). The role of mast cells (MCs), which are members of the sentinel immune cell population, is unknown in intestinal fibrosis.

METHODS:

In this study, we analyzed changes in MCs, tryptase proteins, and ECM components in human fibrotic and control patient intestines. We constructed dextran sodium sulfate-induced intestinal fibrosis models using wild-type mice, MC-reconstituted mice, and MC-deficient mice to explore the role of MCs and tryptase in intestinal fibrosis. The roles and mechanisms of MCs and tryptase on fibroblasts were evaluated using human MCs (HMC-1 and LAD-2), commercial tryptase proteins, human colon fibroblasts (CCD-18Co fibroblasts), the tryptase inhibitor APC366, and the protease-activated receptor-2 (PAR-2) antagonist ENMD-1068.

RESULTS:

Regardless of whether the colon was a human colon or a mouse colon, the fibrotic intestinal tissue had increased MC infiltration and a higher expression of ECM proteins or genes than that of the control group. The dextran sodium sulfate-induced intestinal fibrosis in MC-deficient mice was alleviated compared with that in wild-type mice. After MC reconstruction in MC-deficient mice, the alleviating effect disappeared. Tryptase, as a content stored in MC granules, was released into fibrotic intestinal tissues in the form of degranulation, resulting in an increased expression of tryptase. Compared with the control group, the tryptase inhibition group (the APC366 group) had reduced intestinal fibrosis. The CCD-18Co fibroblasts, when cocultured with MCs or treated with tryptase proteins, were activated to differentiate into myofibroblasts and secrete more ECM proteins (such as collagen and fibronectin). The underlying mechanism of fibroblast activation by tryptase was the activation of the PAR-2/Akt/mTOR pathway.

CONCLUSIONS:

We found that MC tryptase promotes inflammatory bowel disease-induced intestinal fibrosis. The underlying mechanism is that tryptase promotes the differentiation of fibroblasts into fibrotic-phenotype myofibroblasts by activating the PAR-2/Akt/ mTOR pathway of fibroblasts.

• Authors: Bin Liu, Mu-Qing Yang, Tian-Yu Yu, Yang-Yang Yin, Ying Liu, Xiao-Dong Wang, Zhi-Gang He, Lu Yin, Chun-Qiu Chen, Ji-Yu Li
• Journal: Inflammatory bowel diseases (Inflamm Bowel Dis) Vol. 27 Issue 2 Pg. 242-255 (01 19 2021) ISSN: 1536-4844 [Electronic] England
• PMID: 32507895 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: [email protected].

Chemical References

• Dextrans
• Receptor, PAR-2
• Proto-Oncogene Proteins c-akt
• TOR Serine-Threonine Kinases
• Tryptases

Topics

• Animals
• Colitis (chemically induced, pathology)
• Dextrans
• Fibroblasts (cytology)
• Fibrosis
• Humans
• Inflammation (pathology)
• Inflammatory Bowel Diseases (chemically induced, pathology)
• Intestines (pathology)
• Mast Cells (enzymology)
• Mice
• Proto-Oncogene Proteins c-akt
• Receptor, PAR-2
• TOR Serine-Threonine Kinases
• Tryptases (adverse effects)